OTHER GROUP COMPANIES
market

Vanta Bioscience ends 9% higher after receiving order worth Rs1.18cr from Coromandel International

This prestigious order also marks the official initiation of studies of the company’s Phys-chem vertical.

January 04, 2022 4:45 IST | India Infoline News Service
Vanta Bioscience
Vanta Bioscience Ltd has informed that the Company has received an order of Rs1.18cr from Coromandel International Limited, India for carrying out various preclinical studies/toxicity studies on animals, agrochem studies and other studies.

This prestigious order also marks the official initiation of studies of the company’s Phys-chem vertical.

The said studies will be carried out by the Company from its state of art research facility at Gummidipundi, Chennai.

Vanta Bioscience ended at Rs129.85 apiece up by Rs11.15 or 9.39% on Sensex.

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity